Immune response after autologous hematopoietic stem cell transplantation in type 1 diabetes mellitus
文献类型:期刊论文
作者 | Ye, Lei1,2,3; Li, Li1,2,3; Yang, Minglan1,2,3; Hong, Jie1,2,3; Gu, Weiqiong1,2,3; Wang, Weiqing1,2,3; Ning, Guang1,2,3; Wan, Bing4,5,6; Ning, Guang7; , |
刊名 | STEM CELL RESEARCH & THERAPY |
出版日期 | 2017 |
卷号 | 8期号:-页码:90 |
ISSN号 | 1757-6512 |
关键词 | Hematopoietic stem cell Type 1 diabetes mellitus Immune response Th1 cell Th17 cell Regulartory T cell |
DOI | 10.1186/s13287-017-0542-1 |
文献子类 | Article |
英文摘要 | Background: This study explored the details of the immune response after autologous hematopoietic stem cell transplantation (AHSCT) treatment in type 1 diabetes mellitus. Methods: Peripheral blood mononuclear cells (PBMCs) from 18 patients with type 1 diabetes mellitus were taken at baseline and 12 months after AHSCT or insulin-only therapy. The lymphocyte proliferation, mRNA expression and secretion of pro-inflammatory and anti-inflammatory cytokines belonging to T-helper type 1 (Th1), T-helper type 17 (Th17) and regulatory T (Treg) cells in PBMC culture supernatants were assessed. Results: Compared with patients receiving insulin-only treatment, the patients receiving AHSCT treatment showed better residual C-peptide secretion, lower anti-GAD titers and less exogenous insulin dosages after 12 months of follow-up. AHSCT treatment was associated with significantly reduced Th1 and Th17 cell proportions as well as decreased IFN-gamma, IL-2, IL-12p40 and IL-17A levels in the PBMC culture supernatants (all P < 0.05). Although there was no significant Treg cell expansion after AHSCT treatment, we observed increased IL-10, TGF-beta and Foxp3 mRNA expression and increased TGF-beta levels. However, we found no significant changes in the T-cell subpopulations after insulin treatment, except for higher IL-12p40 mRNA expression and a lower proportion of Treg cells. Conclusions: AHSCT treatment was associated with decreased expansion and function of Th1 and Th17 cells, which may explain the better therapeutic effect of AHSCT compared with the traditional intensive insulin therapy. |
学科主题 | Cell Biology ; Research & Experimental Medicine |
WOS关键词 | T-CELLS ; AUTOIMMUNE-DISEASES ; MULTIPLE-SCLEROSIS ; TH17 CELLS ; FOLLOW-UP ; CHILDREN ; SUPPRESSION ; MECHANISMS |
语种 | 英语 |
出版者 | BIOMED CENTRAL LTD |
WOS记录号 | WOS:000399463400011 |
版本 | 出版稿 |
源URL | [http://202.127.25.144/handle/331004/1149] |
专题 | 中国科学院上海生命科学研究院营养科学研究所 |
作者单位 | 1.Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Endocrinol & Metab,Shanghai Inst Endocrine &, 197 Ruijin 2nd Rd, Shanghai 200025, Peoples R China; 2.Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Endocrine & Metab E Inst Shanghai Univ, 197 Ruijin 2nd Rd, Shanghai 200025, Peoples R China; 3.Chinese Hlth Minist, Key Lab Endocrinol & Metab, 197 Ruijin 2nd Rd, Shanghai 200025, Peoples R China; 4.Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai Inst Immunol, Shanghai, Peoples R China; 5.Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China; 6.SJTUSM, Shanghai, Peoples R China; 7.Shanghai Jiao Tong Univ, Chinese Acad Sci, Shanghai Inst Biol Sci, Sch Med,Lab Endocrinol & Metab,Inst Hlth Sci, Shanghai, Peoples R China, |
推荐引用方式 GB/T 7714 | Ye, Lei,Li, Li,Yang, Minglan,et al. Immune response after autologous hematopoietic stem cell transplantation in type 1 diabetes mellitus[J]. STEM CELL RESEARCH & THERAPY,2017,8(-):90. |
APA | Ye, Lei.,Li, Li.,Yang, Minglan.,Hong, Jie.,Gu, Weiqiong.,...&,.(2017).Immune response after autologous hematopoietic stem cell transplantation in type 1 diabetes mellitus.STEM CELL RESEARCH & THERAPY,8(-),90. |
MLA | Ye, Lei,et al."Immune response after autologous hematopoietic stem cell transplantation in type 1 diabetes mellitus".STEM CELL RESEARCH & THERAPY 8.-(2017):90. |
入库方式: OAI收割
来源:上海营养与健康研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。